LAVAL, QC, Feb. 17, 2021 /CNW Telbec/ - Subsequent to its global distribution agreement with SD Biosensor Inc., Roche Diagnostics, a division of Hoffmann-La Roche Limited, announces that its SARS-CoV-2 Rapid Antigen Test has received approval under Health Canada's Interim Order. This can help healthcare professionals identify a SARS-CoV-2 infection with results typically ready in 15 minutes. 2